Your session is about to expire
← Back to Search
Study Summary
This trial will study whether ketamine can help treat depression or PTSD by measuring its impact on epigenetic aging.
- Depression
- Post-Traumatic Stress Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are recruitment efforts still ongoing for this clinical trial?
"Yes, this study requires more participants and was last updated on September 7th, 2022. The clinicaltrials website has the original posting date as April 1st, 2022."
Is this research project only available to adults aged 25 and up?
"Eligibility for this specific clinical trial is restricted to patients aged 18-64. Out of the 1164 clinical trials available for people over 65 and the 222 trials geared towards those under 18, this is the only one that meets your age criteria."
How many people total are included in this clinical trial?
"The clinical trial is still seeking participants, according to the information on clinicaltrials.gov. The study was originally posted on 4/1/2022 and was most recently edited on 9/7/2022. They are recruiting for 20 participants between 1 sites."
Is Ketamine a short-term or long-term solution?
"There is some data supporting Ketamine's safety, but nothing concretely linking it to efficacy. As such, we've given it a score of 2."
Might I be a right candidate for this clinical trial?
"The requirements for this study are that participants must have a diagnosis of depression and be within the specified age range. So far, 20 people have been enrolled in the trial."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger